APA (7th ed.) Citation

J, F., E, T., KA, Z., RR, S., N, K., C, K., . . . S, B. (2026). The pathogenesis of therapy-related myeloid neoplasms from TP53-mutant clonal hematopoiesis. Leukemia, 40(2), 279. https://doi.org/10.1038/s41375-025-02839-5

Chicago Style (17th ed.) Citation

J, Fullin, et al. "The Pathogenesis of Therapy-related Myeloid Neoplasms from TP53-mutant Clonal Hematopoiesis." Leukemia 40, no. 2 (2026): 279. https://doi.org/10.1038/s41375-025-02839-5.

MLA (9th ed.) Citation

J, Fullin, et al. "The Pathogenesis of Therapy-related Myeloid Neoplasms from TP53-mutant Clonal Hematopoiesis." Leukemia, vol. 40, no. 2, 2026, p. 279, https://doi.org/10.1038/s41375-025-02839-5.